Home › Papillary Thyroid Cancer
Papillary Thyroid Cancer clinical trials recruiting in the U.S.
7 studies for Papillary Thyroid Cancer are recruiting participants at sites across the United States.
Cities with the most studies
By state
Recently updated studies
Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07140757Studies on Tumors of the Thyroid
RecruitingObservational study
6 Months – 98 Years · All sexes · Updated Aug 31, 2026 · NCT00001160Health and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyroid Cancer Survivors
Recruiting
Ages 18 and older · All sexes · Updated Jul 8, 2026 · NCT07545837XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 26, 2026 · NCT06959641Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 2, 2026 · NCT06440850Targeted Therapy to Increase RAI Uptake in Metastatic DTC
RecruitingObservational study
Ages 0 and older · All sexes · Updated Nov 14, 2025 · NCT05024929Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Dec 12, 2024 · NCT05668962From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.